Gabriele-Cornelia Dr. Fox

Gabriele-Cornelia Dr. Fox is a highly experienced professional in the field of pharmacovigilance, currently serving as Vice President and Global Head of Pharmacovigilance at Chiesi Group since October 2023. Prior to this role, Gabriele-Cornelia held the position of Vice President, EU and International Qualified Person for Pharmacovigilance at CSL Vifor from 2020 to September 2023. Gabriele-Cornelia's extensive career includes significant positions at Merck Gruppe as Director of Drug Safety and Clinical Development and EU QPPV, as well as leadership roles at Indivumed Inc., Orion Pharma Ltd, Ferring Pharmaceuticals, and the DKFZ German Cancer Research Center. Gabriele-Cornelia holds a Staatsexamen from Freie Universität Berlin and a Ph.D. from DKFZ.